Transcriptomic profiles of colorectal cancer: An Individual Patient Data meta-analysis
Aristotle University of Thessaloniki · 01.01.2026
DOI: 10.26262/heal.auth.ir.373908 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Aristotle University of Thessaloniki, erschienen am 01.01.2026. Verfasst von Θωμάς Σ. Μανώλης.
Abstract (Originalsprache)
The current thesis attempted to explore the relationship between the transcriptome appearing in colon cancer, and specifically in that which appears in the sigmoid colon and rectum, and the response of patients to chemotherapy. This disease is the 3rd most common malignancy worldwide and the second cause of death among malignant tumors. As the 21st century is characterized as the century of molecular biology, the study of the molecular profile of every patient adds one more level to their treatment plan, leading to a more specialized and effective cure. Hence, we sought to research the association between the transcriptional landscape (meaning the whole mRNA expressed in cancer cells and thus indirectly their gene expression pattern) of this specific cancer and the efficacy of 5-fluorouracil-based regimens. Given that 5-fluorouracil remains the primary therapeutic modality, understanding the relationship between mRNA abundance and drug sensitivity is critical for predicting patient outcomes. Our goal was to discover a gene or genes that are either overexpressed or underexpressed and this expression pattern appears to be statistically significant in patients under the specific treatment, showing resistance to it. Applying that possible discovery to all our data could then create a pattern that can be generalized and therefore ultimately have application, as far as the scope of our analysis allows, in clinical practice. Using the computational tools for statistical analysis of genetic information of the R language and the RStudio programming environment, we calculated basic metrics used in such analyses (e.g. the Log2 Fold Change) from 4 different datasets. We then performed a special type of meta-analysis, which is the strongest form of evidence, the individual patient data meta-analysis (IPD Meta-analysis) in order to draw conclusions about whether the changes in the expression of the main genes that we identified from the analysis are statistically significant or the result is due to limitations arising from the data (volume, quality) and the method of analysis. Finally, we proceeded with the analysis of the statistically significant genes to further examine the biochemical pathways in which they are involved, trying to highlight how and why these patients develop resistance to drugs containing 5-Fluorouracil. We thus came to an interesting conclusion, which could help the clinician, along with other information he has about the patient, to understand why the patient is possibly not responding to their treatment or assist them to choose a therapeutic strategy in the early stages of therapy, hence contributing to what is called "personalized medicine."
Schlagwörter
Zitieren
APA
Μανώλης, Θ. Σ. (2026). Transcriptomic profiles of colorectal cancer: An Individual Patient Data meta-analysis. Aristotle University of Thessaloniki. https://doi.org/10.26262/heal.auth.ir.373908
Vancouver
Μανώλης ΘΣ. Transcriptomic profiles of colorectal cancer: An Individual Patient Data meta-analysis. Aristotle University of Thessaloniki. 2026. doi:10.26262/heal.auth.ir.373908
BibTeX
@article{2026,
author = {Μανώλης, Θωμάς Σ.},
title = {Transcriptomic profiles of colorectal cancer: An Individual Patient Data meta-analysis},
journal = {Aristotle University of Thessaloniki},
year = {2026},
doi = {10.26262/heal.auth.ir.373908}
}
EUVIMED